{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T14:39:00Z","timestamp":1767969540881,"version":"3.49.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T00:00:00Z","timestamp":1614643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>The purpose of this study was to evaluate the efficacy and safety of iodine-125 (<jats:sup>125<\/jats:sup>I) seeds implantation under ultrasound and computed tomography (CT) guidance in the treatment of residual hepatocellular carcinoma (HCC) located at complex sites after transcatheter arterial chemoembolization (TACE).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective study analyzed the consecutive medical records of 31 HCC patients with residual tumors located at complex sites (such as large blood vessels, gallbladder, diaphragm dome, etc.) after TACE from May 2014 to December 2018, all of whom received <jats:sup>125<\/jats:sup>I seeds implantation therapy. Overall survival (OS), progression-free survival (PFS), recurrence, and complications were documented.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 607 seeds were implanted in 31 patients, with an average of 19.6\u00b110.4 (range, 8\u201348) seeds per patient. Median OS and PFS were 33 months (95% CI: 27.1 months, 38.9 months) and 15 months (95% CI: 9.6 months, 20.4 months), respectively. Although univariate analysis showed that albumin, prothrombin time, alpha-fetoprotein level, Child-Pugh score, and lipiodol deposition in tumor were associated with OS, multivariate analysis showed that none of them was an independent prognostic factor for OS. Multivariate analysis showed that prothrombin time was an independent prognostic factor for PFS. No operation-related deaths in this study. Although pneumothorax was present in two patients and subcutaneous abscess in one patient, symptoms improved in all three patients with appropriate treatment. Common minor complications included fever, abdominal pain and leukopenia and no grade\u22653 adverse events were observed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p><jats:sup>125<\/jats:sup>I seeds implantation under the combined guidance of ultrasound and CT is safe and effective for patients with residual HCC located at complex sites after TACE. This is a promising treatment approach and deserves further discussion.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2021.582544","type":"journal-article","created":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T07:48:32Z","timestamp":1614671312000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Combined Ultrasound and CT-Guided Iodine-125 Seeds Implantation for Treatment of Residual Hepatocellular Carcinoma Located at Complex Sites After Transcatheter Arterial Chemoembolization"],"prefix":"10.3389","volume":"11","author":[{"given":"Yanqiao","family":"Ren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangjun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamah","family":"Alwalid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuefeng","family":"Kan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangbo","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huimin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuansheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.15403\/jgld.2014.1121.274.fcr","article-title":"Predictive Factors of Tumor Recurrence and Survival in Patients with Hepatocellular Carcinoma treated with Transarterial Chemoembolization","volume":"27","author":"Cerban","year":"2018","journal-title":"J Gastrointestin Liver Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation vs. symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma","volume":"35","author":"Lo","year":"2002","journal-title":"Hepatology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50047","article-title":"Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival","volume":"37","author":"Llovet","year":"2003","journal-title":"Hepatology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.brachy.2018.12.008","article-title":"125I seeds implantation for treating residual hepatocellular carcinoma located beneath the diaphragm after transcatheter arterial chemoembolization","volume":"18","author":"Li","year":"2019","journal-title":"Brachytherapy"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.07.017","article-title":"Comparative study between doxorubicineluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma","volume":"57","author":"Song","year":"2012","journal-title":"J Hepatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2009.10.038","article-title":"Transarterial chemoembolization with epirubicin-eluting beads versus transarterial embolization before liver transplantation for hepatocellular carcinoma","volume":"21","author":"Nicolini","year":"2010","journal-title":"J Vasc Interv Radiol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i45.17206","article-title":"Conventional transarterial chemoembolization vs microsphere embolization in hepatocellular carcinoma: a meta-analysis","volume":"20","author":"Ni","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.05.021","article-title":"Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients","volume":"131","author":"Takayasu","year":"2006","journal-title":"Gastroenterology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2015.10.006","article-title":"Incidence and therapeutic frequency of extrahepatic collateral arteries in transcatheter arterial chemoembolization of hepatocellular carcinoma: Experience from 182 patients with survival time more than 3 years","volume":"84","author":"Li","year":"2015","journal-title":"Eur J Radiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12621","article-title":"Survival benefit of radioembolization for inoperable hepatocellular carcinoma using yttrium-90 microspheres","volume":"29","author":"Kwok","year":"2014","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0b013e32836141a0","article-title":"Intra-arterial injection of 131I-labeled Lipiodol for advanced hepatocellular carcinoma: a 7 years\u2019 experience","volume":"34","author":"Lintia-Gaultier","year":"2013","journal-title":"Nucl Med Commun"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.218776","article-title":"Magnetic resonance imaging-guided percutaneous cryoablation of hepatocellular carcinoma in special regions","volume":"9","author":"Wu","year":"2010","journal-title":"HBPD Int"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.02275.x","article-title":"CT-guided treatment of ultrasonically invisible hepatocellular carcinoma","volume":"95","author":"Sato","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2231010862","article-title":"CT-guided thransthoracic percutaneous ethanol injection for hepatocellular carcinoma not detectable with US","volume":"223","author":"Shibata","year":"2002","journal-title":"Radiology"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/00004728-200307000-00025","article-title":"Computed tomography demonstration of immediate and delayed complications of computed tomography-guided thranthoracic percutaneous ethanol injection of hepatocellular carcinoma at the liver dome","volume":"27","author":"Tsai","year":"2003","journal-title":"J Comput Assist Tomogr"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S212127","article-title":"Combined ultrasound\/computed tomography guidance in percutaneous radiofrequency ablation after transarterial chemoembolization for hepatocellular carcinoma in the hepatic dome","volume":"11","author":"Kan","year":"2019","journal-title":"Cancer Manag Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2012.05.007","article-title":"Treatment of hepatocellular carcinoma adjacent to large blood vessels using 1.5T MRI-guided percutaneous radiofrequency ablation combined with iodine-125 radioactive seed implantation","volume":"81","author":"Lin","year":"2012","journal-title":"Eur J Radiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2017.12.273","article-title":"Does Seed Migration Increase the Risk of Second Malignancies in Prostate Cancer Patients Treated With Iodine-125 Loose Seeds Brachytherapy","volume":"100","author":"Vigneault","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2018.10.034","article-title":"The Effectiveness and Prognostic Factors of CT-Guided Radioactive I-125 Seed Implantation for the Treatment of Recurrent Head and Neck Cancer After External Beam Radiation Therapy","volume":"103","author":"Ji","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1080\/09553002.2020.1704300","article-title":"A review on the efficacy and safety of iodine-125 seed implantation in unresectable pancreatic cancers","volume":"96","author":"Jia","year":"2020","journal-title":"Int J Radiat Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.10.030","article-title":"Mature follow-up for high-risk stage I non-small-cell lung carcinoma treated with sublobar resection and intraoperative iodine-125 brachytherapy","volume":"79","author":"Colonias","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.12.10.17676","article-title":"Efficacy of therapy for hepatocellular carcinoma with portal vein tumor thrombus: chemoembolization and stent combined with iodine-125 seed","volume":"12","author":"Chuan-Xing","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3048261","DOI":"10.1155\/2016\/3048261","article-title":"Portal Vein Stenting Combined with Iodine-125 Seeds Endovascular Implantation Followed by Transcatheter Arterial Chemoembolization for Treatment of Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus","volume":"2016","author":"Sun","year":"2016","journal-title":"BioMed Res Int"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e8660","DOI":"10.1097\/MD.0000000000008660","article-title":"Y-configuration stent combined with iodine-125 seeds strand for the treatment of hepatocellular carcinoma with tumor thrombosis in portal vein branches: A case report","volume":"96","author":"Tan","year":"2017","journal-title":"Med (Baltimore)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.07.026","article-title":"Increased survival in hepatocellular carcinoma with iodine-125 implantation plus radiofrequency ablation: a prospective randomized controlled trial","volume":"61","author":"Chen","year":"2014","journal-title":"J Hepatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.08.029","article-title":"Long-term follow-up of patients of intrahepatic malignancies treated with iodine-125 brachytherapy","volume":"64","author":"Nag","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2017.1370728","article-title":"Computed tomography-guided percutaneous microwave ablation of hepatocellular carcinoma in challenging locations: safety and efficacy of high-power microwave platforms","volume":"34","author":"Filippiadis","year":"2018","journal-title":"Int J Hyperthermia"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20933","article-title":"Management of hepatocellular carcinoma","volume":"42","author":"Bruix","year":"2005","journal-title":"Hepatology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.14132958","article-title":"Image-guided tumor ablation: standardization of terminology and reporting criteria\u2013a 10-year update","volume":"273","author":"Ahmed","year":"2014","journal-title":"Radiology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2013.229","article-title":"Local recurrence of hepatocellular carcinoma in the tumor blood drainage area following radiofrequency ablation","volume":"2","author":"Hirooka","year":"2014","journal-title":"Mol Clin Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1097\/01.RVI.0000092666.72261.6B","article-title":"Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors","volume":"14","author":"Lu","year":"2003","journal-title":"J Vasc Interv Radiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.07.2537","article-title":"Combined percutaneous radiofrequency ablation and ethanol injection for hepatocellular carcinoma in high-risk locations","volume":"190","author":"Wong","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1038\/s41598-017-03831-5","article-title":"Iodine-125 Brachytherapy Prophylaxis after Radiofrequency Ablation Cannot Benefit Patients in High Risk of Locoregional Hepatocellular Carcinoma Recurrence","volume":"7","author":"Tu","year":"2017","journal-title":"Sci Rep"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2016.06.007","article-title":"Iodine-125 implantation plus transarterial chemoembolization for the treatment of hepatocellular carcinoma of 3-5cm: A propensity score matching study","volume":"48","author":"Li","year":"2016","journal-title":"Dig Liver Dis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e57397","DOI":"10.1371\/journal.pone.0057397","article-title":"Adjuvant iodine-125 brachytherapy for hepatocellular carcinoma after complete hepatectomy: a randomized controlled trial","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.brachy.2019.05.011","article-title":"The early evaluation of ultrasound-guided iodine-125 interstitial implants for high-risk hepatocellular carcinoma","volume":"18","author":"Zhang","year":"2019","journal-title":"Brachytherapy"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.582544\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T07:48:34Z","timestamp":1614671314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.582544\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,2]]},"references-count":38,"alternative-id":["10.3389\/fonc.2021.582544"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.582544","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,2]]},"article-number":"582544"}}